Publications en collaboration avec des chercheurs de Hôpital Européen Georges-Pompidou (22)

2024

  1. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial

    Thrombosis Research, Vol. 235, pp. 79-87

  2. Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

    European Journal of Internal Medicine

  3. Risk stratification of acute pulmonary embolism

    Presse Medicale

  4. Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis

    European Heart Journal, Vol. 45, Núm. 32, pp. 2933-2950

2023

  1. Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis

    Thrombosis Research

2022

  1. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 857-866

2021

  1. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

    The Lancet Haematology, Vol. 8, Núm. 9, pp. e627-e636

  2. Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19

    Seminars in Thrombosis and Hemostasis, Vol. 47, Núm. 4, pp. 351-361

  3. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: The HOME-PE randomized trial

    European Heart Journal, Vol. 42, Núm. 33, pp. 3146-3157

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

    Clinical Research in Cardiology, Vol. 108, Núm. 7, pp. 772-778

2018

  1. Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study

    Journal of Thrombosis and Haemostasis, Vol. 16, Núm. 6, pp. 1069-1077

  2. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism

    Thrombosis Research, Vol. 163, pp. 128-131

2017

  1. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

    Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434

  2. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

    Journal of the American College of Cardiology, Vol. 69, Núm. 12, pp. 1536-1544

  3. Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism

    European Respiratory Journal, Vol. 50, Núm. 6

2016

  1. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: A pooled analysis of 926 patients

    Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 1, pp. 105-113

2015

  1. Risk assessment and management of high and intermediate risk pulmonary embolism

    Presse Medicale

  2. Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism

    Chest, Vol. 148, Núm. 1, pp. 211-218